Condensed Consolidated Statements of Cash Flows (unaudited) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2025	Mar. 31, 2024
Cash flows provided by (used in) operating activities:
Net earnings	$ 182.6	$ 172.8
Adjustments to reconcile net earnings to cash provided by operating activities:
Depreciation and amortization	254.4	238.6
Share-based compensation	19.6	29.0
Changes in operating assets and liabilities, net of acquired assets and liabilities
Income taxes	(15.6)	(8.6)
Receivables	(18.8)	(22.7)
Inventories	(3.0)	(55.3)
Accounts payable and accrued liabilities	(36.4)	(119.4)
Other assets and liabilities	(0.1)	(6.4)
Net cash provided by operating activities	382.8	228.0
Cash flows provided by (used in) investing activities:
Additions to instruments	(59.7)	(82.0)
Additions to other property, plant and equipment	(44.6)	(55.1)
Net investment hedge settlements	1.0	10.2
Acquisition of intangible assets	(2.4)	(43.3)
Other investing activities	(0.3)	(24.8)
Net cash used in investing activities	(106.0)	(195.0)
Cash flows provided by (used in) financing activities:
Net proceeds from revolving facilities	0.0	70.0
Proceeds from senior notes	1,748.1
Redemption of senior notes	(863.0)
Dividends paid to stockholders	(47.8)	(49.4)
Proceeds from employee stock compensation plans	16.7	56.4
Business combination contingent consideration payments	(17.4)	(1.5)
Debt issuance costs	(16.1)
Deferred business combination payments	0.0	(1.5)
Repurchase of common stock	(229.8)	(113.6)
Other financing activities	(15.2)	(10.5)
Net cash provided by (used in) financing activities	575.4	(50.1)
Effect of exchange rates on cash and cash equivalents	7.0	(5.7)
Change in cash and cash equivalents	859.1	(22.7)
Cash and cash equivalents, beginning of year	525.5	415.8
Cash and cash equivalents, end of period	$ 1,384.5	$ 393.0